Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$24.16
+4.45%
Mkt Cap $3.79B
Analyst Ratings
Buy
16
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
Implied Upside
+43.2%
Consensus $34.60 vs current $24.16
NASDAQ·Healthcare·Biotechnology
$24.16
+4.45%
Mkt Cap $3.79B
Buy
16
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
+43.2%
Consensus $34.60 vs current $24.16